Drugs / Bisphosphocin Nu-3
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02737722 | Apr 2016 → Aug 2017 | — | Lakewood-Amedex Inc | Completed | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bisphosphocin Nu-3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02737722 ↗ |
| Modality | Small molecule | — CHEMBL4297360 ↗ |
| Route | Topical | “Bisphosphocin Nu-3 will be applied topically to the chronic infected ulcer” NCT02737722 ↗ |